Literature DB >> 11294940

Amygdala and hippocampal volumes in children with Down syndrome: a high-resolution MRI study.

J D Pinter1, W E Brown, S Eliez, J E Schmitt, G T Capone, A L Reiss.   

Abstract

The objective of this study was to use high-resolution MRI techniques to determine whether children with Down syndrome exhibit decreases in hippocampal and amygdala volumes similar to those demonstrated in recent studies of adults with this condition. When corrected for overall brain volumes, amygdala volumes did not differ between groups but hippocampal volumes were significantly smaller in the Down syndrome group. These findings suggest that the hippocampal volume reduction seen in adults with Down syndrome may be primarily due to early developmental differences rather than neurodegenerative changes.

Entities:  

Mesh:

Year:  2001        PMID: 11294940     DOI: 10.1212/wnl.56.7.972

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  50 in total

1.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

2.  Developmentally altered inhibition in Ts65Dn, a mouse model of Down syndrome.

Authors:  Ananya Mitra; Martina Blank; Daniel V Madison
Journal:  Brain Res       Date:  2012-01-03       Impact factor: 3.252

3.  Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome.

Authors:  Chie Harashima; David M Jacobowitz; Jassir Witta; Rosemary C Borke; Tyler K Best; Richard J Siarey; Zygmunt Galdzicki
Journal:  J Comp Neurol       Date:  2006-02-10       Impact factor: 3.215

4.  Quantitative MRI Analyses of Regional Brain Growth in Living Fetuses with Down Syndrome.

Authors:  Tomo Tarui; Kiho Im; Neel Madan; Rajeevi Madankumar; Brian G Skotko; Allie Schwartz; Christianne Sharr; Steven J Ralston; Rie Kitano; Shizuko Akiyama; Hyuk Jin Yun; Ellen Grant; Diana W Bianchi
Journal:  Cereb Cortex       Date:  2020-01-10       Impact factor: 5.357

Review 5.  Visuo-spatial ability in individuals with Down syndrome: is it really a strength?

Authors:  Yingying Yang; Frances A Conners; Edward C Merrill
Journal:  Res Dev Disabil       Date:  2014-04-20

6.  Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region.

Authors:  Wei Liu; Hui Zhou; Lei Liu; Chuntao Zhao; Yaqi Deng; Lina Chen; Laiman Wu; Nicole Mandrycky; Christopher T McNabb; Yuanbo Peng; Perry N Fuchs; Jie Lu; Volney Sheen; Mengsheng Qiu; Meng Mao; Q Richard Lu
Journal:  Neurobiol Dis       Date:  2015-03-05       Impact factor: 5.996

7.  Similar nicotinic excitability responses across the developing hippocampal formation are regulated by small-conductance calcium-activated potassium channels.

Authors:  Beryl Y T Chung; Craig D C Bailey
Journal:  J Neurophysiol       Date:  2018-01-31       Impact factor: 2.714

8.  Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.

Authors:  Chelsee A Hewitt; King-Hwa Ling; Tobias D Merson; Ken M Simpson; Matthew E Ritchie; Sarah L King; Melanie A Pritchard; Gordon K Smyth; Tim Thomas; Hamish S Scott; Anne K Voss
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

9.  Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn.

Authors:  G Pollonini; V Gao; A Rabe; S Palminiello; G Albertini; C M Alberini
Journal:  Neuroscience       Date:  2008-07-25       Impact factor: 3.590

10.  Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome.

Authors:  Elise Morice; Laura C Andreae; Sam F Cooke; Lesley Vanes; Elizabeth M C Fisher; Victor L J Tybulewicz; Timothy V P Bliss
Journal:  Learn Mem       Date:  2008-07-14       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.